Skip to content
Nonprofiteer
← ALS CURE PROJECT INC

Form 990 for tax year 2024

Filed by ALS CURE PROJECT INC.

Totals

Total revenue
$860,387
Total expenses
$219,071
Contributions and grants received
$801,575
Grants paid
$213,000
Program service revenue
$0
Investment income
$0
Other revenue
$58,812
Total assets, end of year
$739,634
Total liabilities, end of year
$0
Net assets or fund balances, end of year
$739,634
Program services expenses (Part IX)
$213,000
Management and general expenses
$1,554
Fundraising expenses
$4,517
Program service expenses (Part III)
$213,000

Program services were 97.2% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1c · Fundraising events

    $801,575

  • 8a · Fundraising events: gross income

    $259,505

  • 8a · Fundraising events: contributions included on line 1c

    $801,575

  • 8b · Fundraising events: direct expenses

    $200,693

  • 8c · Net income from fundraising events

    total $58,812

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $213,000 · program services $213,000

  • 2 · Grants to domestic individuals

    total $0

  • 3 · Grants to foreign organizations and individuals

    total $0

  • 4 · Benefits paid to or for members

    total $0

  • 5 · Compensation of officers, directors and key employees

    total $0

  • 6 · Compensation of disqualified persons

    total $0

  • 7 · Other salaries and wages

    total $0

  • 8 · Pension plan contributions

    total $0

  • 9 · Other employee benefits

    total $0

  • 10 · Payroll taxes

    total $0

  • 11a · Fees: management

    total $0

  • 11b · Fees: legal

    total $0

  • 11c · Fees: accounting

    total $0

  • 11d · Fees: lobbying

    total $0

  • 11f · Fees: investment management

    total $0

  • 11g · Fees: other

    total $0

  • 12 · Advertising and promotion

    total $0

  • 13 · Office expenses

    total $2,567 · fundraising $2,567

  • 14 · Information technology

    total $1,950 · fundraising $1,950

  • 15 · Royalties

    total $0

  • 16 · Occupancy

    total $0

  • 17 · Travel

    total $0

  • 18 · Travel or entertainment for public officials

    total $0

  • 19 · Conferences, conventions and meetings

    total $0

  • 20 · Interest

    total $0

  • 21 · Payments to affiliates

    total $0

  • 22 · Depreciation, depletion and amortization

    total $0

  • 23 · Insurance

    total $1,554 · management and general $1,554

  • 24e · All other expenses

    total $0

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $98,318 · end of year $739,634

  • 27 · Net assets without donor restrictions

    beginning of year $98,318 · end of year $739,634

Mission and programs · 2024

Mission

This year the ALS Cure Project in collabortion with Canadian and US partners continued to fund the multimodal Longitudinal Modeling project along with the Drug Repurposing Project

Activities or mission (Part I)

The specfic purpose of the Organization shall include without limitation, to lead scientific research focused on the identification of Amyotrophic Lateral Scierosis ALS bio-markers and disease mechanism

  • 3ML Multimodal Longitudinal Modeling ProjectThis is a multi-nation collaboration project with Canadian and US partners managed by the President of the ALS CURE Project gratis. The University of Alberta was funded to support coordination activities for the MRI, Blood and speech sample and data collection of the Canadian patients involved with the 3ML project. Stanford University received funding to support the development of the 3ML model. Lawrence Livermore National Laboratory was funded through the Livermore Lab Foundation to provide strategic ML oversight and development of key interfaces.

    Expenses $170,000

  • ALS and Parkinsons Drug Repurposing ProjectThis project is a validation of previous work funded at Lawrence Livermore National Laboratory through the Livermore Lab Foundation LLF was funded to validate results using the Optum dataset. The goal of this project is to use ML learning to analyze medical records of ALS patients to search for existing approved drugs off-target which might be useful in extending the life of ALS and PD patients. Funding partners included, LLF, Stanford, ALS Network and the RDM Positive Impact Foundation.

    Expenses $40,000

  • UC Campus ALS MeetingSponsored the poster session reception at this 2 day conference for UC ALS researchers and ALS funding agencies at the University of California Livermore Collaboration Campus.

    Expenses $3,000

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Mike Piscotty

    President

    Total calculated
    $0
    Hours/week
    10
  • Stephen Piscotty

    VIce President

    Total calculated
    $0
    Hours/week
    1
  • Toni Eslick

    Secretary

    Total calculated
    $0
    Hours/week
    6
  • James Gilbreth

    Fund Raising Director

    Total calculated
    $0
    Hours/week
    6
  • Barron Wesenberg

    Treasurer

    Total calculated
    $0
    Hours/week
    3
  • Andrew Woodward

    IT Communications Director

    Total calculated
    $0
    Hours/week
    3
  • Dave Darby

    Corporate Sponsorship Director

    Total calculated
    $0
    Hours/week
    3
  • Jim Poole

    Strategic Partnership Director

    Total calculated
    $0
    Hours/week
    3

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.

Grants on this return

Fundraising and gaming

From Schedule G of this return, as filed.

Raised funds through (line 1)
special fundraising events
Had an agreement with a professional fundraiser (line 2a)
No
Registered or licensed to solicit in (line 3)
CA

Fundraising events (Part II)

Part II has at most four columns: the two largest events, the rest together, and the total.

Line Event 1 Donna Iannone Bike Event 2 Top Golf Other events 3 events Total
Gross receipts (line 1) $15,501 $43,940 $200,064 $259,505
Less contributions (line 2) $15,166 $11,279 $32,367 $58,812
Gross income (line 3) $335 $32,661 $167,697 $200,693
Cash prizes (line 4) — — — —
Noncash prizes (line 5) — — — —
Rent and facility costs (line 6) — $20,000 $60,000 $80,000
Food and beverages (line 7) — $4,761 $61,519 $66,280
Entertainment (line 8) — — $30,000 $30,000
Other direct expenses (line 9) $335 $7,900 $16,178 $24,413
Direct expenses (line 10)
$200,693
Net income (line 11)
—

Activities outside the United States

From Schedule F of this return, as filed.

At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.

Transferred property to a foreign corporation during the year (line 1)
No
Had an interest in a foreign trust (line 2)
No
Owned an interest in a foreign corporation (line 3)
No
Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
No
Owned an interest in a foreign partnership (line 5)
No
Had operations in or related to a boycotting country (line 6)
No

Provenance

Return type
form_990
Tax year
2024
Filed
15 May 2025
IRS schema version
2024v5.1
Source object
202521399349300507

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.